In this episode of from the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics Internat...
Media Coverage
Medical diagnostics pioneer Proteomics International Laboratories has filled its pockets with a furt...
In the interview, Dr. Lipscombe outlines the four leading tests the company has developed over a per...
The tests could help people with the condition, who often suffer for many years undiagnosed.
After going commercial in August and September with two medical diagnostic products, Proteomics Inte...
Australian diagnostics firm Proteomics International said Wednesday that it has expanded its researc...
Diagnostics trailblazer Proteomics International Laboratories has inked an expanded research deal wi...
Proteomics International Laboratories has received a milestone seal of approval for its industrial-s...
ASX-listed Proteomics International Laboratories is gearing up for the global rollout of its revolut...
A groundbreaking prognostic test developed through collaboration between The University of Western A...
Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has picked up an Australia...
Learn more about our Promarker® tests
Discover our portfolio of prognostic and diagnostic blood tests, developed to predict disease risk earlier and improve patient outcomes.